首页/数据集/Additional file 3: of Genome-scale CRISPR-Cas9 knockout screening in gastrointestinal stromal tumor with Imatinib resistance

Additional file 3: of Genome-scale CRISPR-Cas9 knockout screening in gastrointestinal stromal tumor with Imatinib resistance

NIAID Data Ecosystem2026-03-10 收录

CRISPR-Cas9基因功能研究

化疗耐药机制

数据链接：

https://figshare.com/articles/dataset/Additional_file_3_of_Genome-scale_CRISPR-Cas9_knockout_screening_in_gastrointestinal_stromal_tumor_with_Imatinib_resistance/6964019 数据链接链接失效反馈

官方服务：

资源简介：

Table S2. human geckov2 library b. (XLSX 1864Â kb)

应用场景：

创建时间：

2018-08-14

化疗耐药机制

基因功能验证

The literature evidence for the role of the top 15 genes identified for cisplatin, docetaxel, and doxorubicin in drug sensitivity. Also includes mRNA expression of the genes used in experimental valid

NIAID Data Ecosystem50

Inositol hexaphosphate enhances chemotherapy by reversing persistent endoplasmic reticulum stress-induced senescence in colorectal cancer [RNA-seq II]

化疗耐药机制

药物联合治疗

To investigate if oxaliplatin resistance contributed to persistent endoplasmic reticulum-induced senescence, Overall design: Comparative gene expression profiling analysis of RNA-seq data for HCT 15 c

NIAID Data Ecosystem20

An acetyl-histone vulnerability in PI3K/AKT inhibition resistant cancers is targetable by both BET and HDAC inhibitors

化疗耐药机制

表观遗传治疗

Acquisition of resistance to PI3K/AKT-targeted monotherapy implies the existence of common resistance mechanisms independent of cancer type. Here we demonstrate that PI3K/AKT inhibitors cause glycolyt

NIAID Data Ecosystem10

Identification of Jun loss that promotes resistance to HDAC inhibitor Entinostat through Myc signaling in Luminal breast cancer. Identification of Jun loss that promotes resistance to HDAC inhibitor Entinostat through Myc signaling in Luminal breast cancer

化疗耐药机制

MYC信号通路

This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series

NIAID Data Ecosystem30

DataSheet1_Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma.PDF

肿瘤靶向治疗

化疗耐药机制

Mantle cell lymphoma (MCL) is an incurable B cell non-Hodgkin lymphoma, characterized by frequent relapses. In the last decade, the pro-survival pathways related to BCR signaling and Bcl-2 have been c

NIAID Data Ecosystem20

Additional file 3: of Genome-scale CRISPR-Cas9 knockout screening in gastrointestinal stromal tumor with Imatinib resistance

资源简介：

相关数据集